| Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group (NCT01901133) | Astellas Pharma Europe B.V. | 2011-10-01 |
| Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer (NCT01347866) | Pfizer | 2011-10-01 |
| Optimised Fluoride Prevention by Double Rinse With Fluoride and Calcium (NCT01473537) | Karolinska Institutet | 2011-10-01 |
| Ceftaroline China Pharmacokinetics Study (NCT01458743) | Pfizer | 2011-10-01 |
| Pharmacokinetics and Relative Bioavailability Study (NCT01521767) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-10-01 |
| Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer (NCT01449370) | Millennium Pharmaceuticals, Inc. | 2011-10-01 |
| Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects (NCT02034591) | Bristol-Myers Squibb | 2011-10-01 |
| Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition (NCT02295046) | Dr. Reddy's Laboratories Limited | 2011-10-01 |
| Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (NCT01483534) | Nuvaira, Inc. | 2011-10-01 |
| Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) (NCT01481220) | Nordic MDS Group | 2011-10-01 |
| Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects (NCT01466803) | Turku University Hospital | 2011-10-01 |
| A Study of LY2484595 in Healthy Subjects (NCT01450098) | Eli Lilly and Company | 2011-10-01 |
| The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements (NCT01417299) | Hadassah Medical Organization | 2011-10-01 |
| Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions (NCT01448772) | INSYS Therapeutics Inc | 2011-10-01 |
| Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients (NCT02408185) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2011-10-01 |
| Multiple Dose FSH-GEX(TM) in Healthy Volunteers (NCT01477073) | Glycotope GmbH | 2011-10-01 |
| Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions. (NCT01451775) | Boehringer Ingelheim | 2011-10-01 |
| Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors (NCT01462396) | Children's Mercy Hospital Kansas City | 2011-10-01 |
| Improving Effective Contraceptive Use Among Opioid-maintained Women (NCT01425060) | University of Vermont | 2011-10-01 |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma (NCT01478178) | Kintara Therapeutics, Inc. | 2011-10-01 |
| Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers (NCT01453907) | Elusys Therapeutics | 2011-10-01 |
| Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors (NCT01447225) | Merrimack Pharmaceuticals | 2011-10-01 |
| Lung Cancer Vaccine Plus Oral Dietary Supplement (NCT01829373) | Edward Hirschowitz | 2011-10-01 |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma (NCT01409187) | M.D. Anderson Cancer Center | 2011-10-01 |
| Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging (NCT01693874) | Washington University School of Medicine | 2011-10-01 |
| A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers (NCT01495104) | Hoffmann-La Roche | 2011-10-01 |
| Gene Therapy for Blindness Caused by Choroideremia (NCT01461213) | University of Oxford | 2011-10-01 |
| Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) (NCT01449071) | UCB Pharma | 2011-10-01 |
| Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis (NCT01383603) | Circassia Limited | 2011-10-01 |
| Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury (NCT01446640) | Guangzhou General Hospital of Guangzhou Military Command | 2011-10-01 |
| Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients (NCT01495169) | Vanda Pharmaceuticals | 2011-10-01 |
| Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) (NCT01201694) | M.D. Anderson Cancer Center | 2011-10-01 |
| Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects (NCT01471717) | Bristol-Myers Squibb | 2011-10-01 |
| Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus (NCT01389895) | Amgen | 2011-10-01 |
| A Pharmacokinetics and Safety Study in Subjects With Renal Impairment (NCT01452828) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-10-01 |
| Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene (NCT01487564) | Janssen Research & Development, LLC | 2011-10-01 |
| Acute Carotid Sinus Endovascular Stimulation II Study (NCT01458483) | Medtronic Cardiac Rhythm and Heart Failure | 2011-10-01 |
| A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT01390337) | Daiichi Sankyo | 2011-10-01 |
| DNA Repair Inhibitor & Irradiation on Melanoma (NCT01469455) | DNA Therapeutics | 2011-10-01 |
| A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers (NCT01514929) | Achaogen, Inc. | 2011-10-01 |
| A Safety Study of TTP4000 in Subjects With Alzheimer's Disease (NCT01548430) | vTv Therapeutics | 2011-10-01 |
| AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area (NCT01450293) | University of Oxford | 2011-10-01 |
| Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) (NCT01469078) | Pharmacosmos A/S | 2011-10-01 |
| Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors (NCT01450384) | Virginia Commonwealth University | 2011-10-01 |
| Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma (NCT01175109) | Deric M Park MD | 2011-10-01 |
| A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer (NCT01432886) | Eisai Co., Ltd. | 2011-10-01 |
| Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma (NCT01438554) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-10-01 |
| Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer (NCT01462214) | Hans J. van der Vliet, MD, PhD | 2011-10-01 |
| Study of Axitinib and Temsirolimus in Solid Tumors (NCT01529138) | Emory University | 2011-10-01 |
| A Study to Evaluate the Effect of Clarithromycin on LY2216684 (NCT01460407) | Eli Lilly and Company | 2011-10-01 |
| Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome (NCT01457209) | Göteborg University | 2011-10-01 |
| Drug-drug Interaction Study With Metformin and Imatinib (NCT01404715) | University of California, San Francisco | 2011-10-01 |
| Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer (NCT01347645) | Eisai Inc. | 2011-09-30 |
| BAX 855 Dose-Escalation Safety Study (NCT01599819) | Baxalta now part of Shire | 2011-09-30 |
| Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT01363817) | Bristol-Myers Squibb | 2011-09-28 |
| Ultra Low Dose Interleukin-2 in Healthy Volunteers (NCT01445561) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-09-28 |
| Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults (NCT01458054) | GlaxoSmithKline | 2011-09-27 |
| A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers (NCT02202187) | GlaxoSmithKline | 2011-09-26 |
| Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors (NCT01352962) | National Cancer Institute (NCI) | 2011-09-26 |
| Phase I Biomarker Study (BMS-936558) (NCT01358721) | Bristol-Myers Squibb | 2011-09-23 |
| A Study of BYL719 in Adult Patients With Advanced Solid Malignancies (NCT01387321) | Novartis Pharmaceuticals | 2011-09-22 |
| Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer (NCT01420250) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-09-22 |
| AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors (NCT01362803) | National Cancer Institute (NCI) | 2011-09-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113) (NCT01449461) | Ariad Pharmaceuticals | 2011-09-20 |
| Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (NCT01440998) | National Cancer Institute (NCI) | 2011-09-20 |
| A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function (NCT01331941) | Amgen | 2011-09-19 |
| A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects (NCT01489943) | GlaxoSmithKline | 2011-09-19 |
| Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma (NCT01318317) | City of Hope Medical Center | 2011-09-19 |
| E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck (NCT01332266) | Eisai Inc. | 2011-09-19 |
| A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma (NCT01464112) | Janssen Research & Development, LLC | 2011-09-16 |
| A Study of Lasmiditan on the Heart in Healthy Participants (NCT03465436) | Eli Lilly and Company | 2011-09-16 |
| Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma (NCT01425008) | Millennium Pharmaceuticals, Inc. | 2011-09-15 |
| Experimental PfSPZ Vaccine in Adults Without Malaria (NCT01441167) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-14 |
| Experimental AD4-H5-VTN Vaccine in Healthy Volunteers (NCT01443936) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-14 |
| Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (NCT01430351) | M.D. Anderson Cancer Center | 2011-09-14 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects (NCT01610388) | GlaxoSmithKline | 2011-09-13 |
| Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer (NCT01290354) | GlaxoSmithKline | 2011-09-12 |
| Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma (NCT01421524) | Celgene | 2011-09-12 |
| Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis (NCT01435993) | GlaxoSmithKline | 2011-09-08 |
| Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. (NCT01439152) | Bayer | 2011-09-07 |
| A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer (NCT01326871) | Altor BioScience | 2011-09-06 |
| Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer (NCT01497925) | Polaris Group | 2011-09-06 |
| Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects (NCT01437592) | Novo Nordisk A/S | 2011-09-06 |
| ECI301 and Radiation for Advanced or Metastatic Cancer (NCT01441115) | National Cancer Institute (NCI) | 2011-09-06 |
| Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. (NCT01878890) | Institut Bergonié | 2011-09-05 |
| A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma (NCT01436656) | Pfizer | 2011-09-05 |
| Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS) (NCT01339598) | The University of New South Wales | 2011-09-01 |
| Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65 (NCT01496040) | Nantes University Hospital | 2011-09-01 |
| Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients (NCT02076659) | Philogen S.p.A. | 2011-09-01 |
| Fluid Dairy Products Consumed Before and Within a Pizza Meal on Glycemic Response, Food Intake and Satiety in Children (NCT02147496) | University of Toronto | 2011-09-01 |
| Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV (NCT01570595) | Georgetown University | 2011-09-01 |
| StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns (NCT01437852) | Stratatech, a Mallinckrodt Company | 2011-09-01 |
| Japanese Phase 1 Multiple Ascending Dose (MAD) Study (NCT01396252) | Bristol-Myers Squibb | 2011-09-01 |
| Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. (NCT01535443) | Laboratorios Sophia S.A de C.V. | 2011-09-01 |
| EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA (NCT01384149) | Meir Medical Center | 2011-09-01 |
| Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula (NCT01440699) | Anterogen Co., Ltd. | 2011-09-01 |
| Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects (NCT01469910) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2011-09-01 |
| Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers (NCT01433835) | Microbiotix, Inc. | 2011-09-01 |
| AZD1152 in Diffuse Large B-cell Lymphoma (NCT01354392) | Oxford University Hospitals NHS Trust | 2011-09-01 |
| Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma (NCT01386710) | Northwell Health | 2011-09-01 |